ADC Therapeutics
Develops proprietary antibody drugs targeting cancer
ADC Therapeutics has raised €101M across 2 funding rounds, most recently a Growth/Late round in Sep 2015. Based in Epalinges, Switzerland; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€101M
€100,951,696
Funding rounds
2
Investors
0
distinct backers
Active since
2013-10
latest 2015-09
Funding by year
EUR raised per yearADC Therapeutics — funding by year — interactive chart.
Data table
| ADC Therapeutics — funding by year | |
|---|---|
| 2013 | €30M |
| 2015 | €71M |
Signals
Medium confidenceRaise-next likelihood8
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Growth/Late | €71M | — | View deal → |
| 2013-10-01 | Growth/Late | €30M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData